Stay updated on Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.2 to v3.5.3, indicating a refreshed content version.
    Difference
    0.1%
    Check dated 2026-04-29T09:09:04.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Updated the page footer revision label from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-22T03:23:00.000Z thumbnail image
  4. Check
    46 days ago
    Change Detected
    Summary
    The header now shows Revision: v3.5.0, replacing Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-24T05:48:33.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3. There are no visible changes to study details or outcomes.
    Difference
    0.1%
    Check dated 2026-03-10T00:30:17.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no clinical content, eligibility criteria, results, or critical page data were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-16T15:54:51.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1. This appears to be a metadata update and does not affect core content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-09T12:19:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.